The antigenic targets recognized by naturally occurring CD4+ CD25+ regulatory T cells (T reg cells) have been elusive. We have serologically defined a series of broadly expressed self-antigens derived from chemically induced mouse sarcomas by serological identification of antigens by recombinant expression cloning (SEREX). CD4+ CD25+ T cells from mice immunized with SEREX-defined self-antigens had strong suppressive activity on peptide-specific proliferation of CD4+ CD25− T cells and CD8+ T cells. The suppressive effect was observed without in vitro T cell stimulation. Foxp3 expression in these CD4+ CD25+ T cells from immunized mice was 5–10 times greater than CD4+ CD25+ T cells derived from naive mice. The suppressive effect required cellular contact and was blocked by anti-glucocorticoid–induced tumor necrosis factor receptor family–related gene antibody. In vitro suppressive activity essentially disappeared 8 wk after the last immunization. However, it was regained by in vitro restimulation with cognate self-antigen protein but not with control protein. We propose that SEREX-defined self-antigens such as those used in this study represent self-antigens that elicit naturally occurring CD4+ CD25+ T reg cells.
Skip Nav Destination
Article navigation
7 March 2005
Article Contents
Brief Definitive Report|
March 07 2005
Definition of target antigens for naturally occurring CD4+ CD25+ regulatory T cells
Hiroyoshi Nishikawa,
Hiroyoshi Nishikawa
1Second Department of Internal Medicine, Mie University School of Medicine, Mie 514-8507, Japan
Search for other works by this author on:
Takuma Kato,
Takuma Kato
2Department of Bioregulation, Mie University School of Medicine, Mie 514-8507, Japan
Search for other works by this author on:
Isao Tawara,
Isao Tawara
1Second Department of Internal Medicine, Mie University School of Medicine, Mie 514-8507, Japan
Search for other works by this author on:
Kanako Saito,
Kanako Saito
1Second Department of Internal Medicine, Mie University School of Medicine, Mie 514-8507, Japan
2Department of Bioregulation, Mie University School of Medicine, Mie 514-8507, Japan
Search for other works by this author on:
Hiroaki Ikeda,
Hiroaki Ikeda
1Second Department of Internal Medicine, Mie University School of Medicine, Mie 514-8507, Japan
3Department of Pathology and Immunology, Center for Immunology, Washington University School of Medicine, St. Louis, MO 63110
Search for other works by this author on:
Kagemasa Kuribayashi,
Kagemasa Kuribayashi
2Department of Bioregulation, Mie University School of Medicine, Mie 514-8507, Japan
Search for other works by this author on:
Paul M. Allen,
Paul M. Allen
3Department of Pathology and Immunology, Center for Immunology, Washington University School of Medicine, St. Louis, MO 63110
Search for other works by this author on:
Robert D. Schreiber,
Robert D. Schreiber
3Department of Pathology and Immunology, Center for Immunology, Washington University School of Medicine, St. Louis, MO 63110
Search for other works by this author on:
Shimon Sakaguchi,
Shimon Sakaguchi
4Department of Experimental Pathology, Institute for Frontier Medical Science, Kyoto University, Kyoto 606-8507, Japan
Search for other works by this author on:
Lloyd J. Old,
Lloyd J. Old
5Ludwig Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center, New York, NY 10021
Search for other works by this author on:
Hiroshi Shiku
Hiroshi Shiku
1Second Department of Internal Medicine, Mie University School of Medicine, Mie 514-8507, Japan
Search for other works by this author on:
Hiroyoshi Nishikawa
1Second Department of Internal Medicine, Mie University School of Medicine, Mie 514-8507, Japan
Takuma Kato
2Department of Bioregulation, Mie University School of Medicine, Mie 514-8507, Japan
Isao Tawara
1Second Department of Internal Medicine, Mie University School of Medicine, Mie 514-8507, Japan
Kanako Saito
1Second Department of Internal Medicine, Mie University School of Medicine, Mie 514-8507, Japan
2Department of Bioregulation, Mie University School of Medicine, Mie 514-8507, Japan
Hiroaki Ikeda
1Second Department of Internal Medicine, Mie University School of Medicine, Mie 514-8507, Japan
3Department of Pathology and Immunology, Center for Immunology, Washington University School of Medicine, St. Louis, MO 63110
Kagemasa Kuribayashi
2Department of Bioregulation, Mie University School of Medicine, Mie 514-8507, Japan
Paul M. Allen
3Department of Pathology and Immunology, Center for Immunology, Washington University School of Medicine, St. Louis, MO 63110
Robert D. Schreiber
3Department of Pathology and Immunology, Center for Immunology, Washington University School of Medicine, St. Louis, MO 63110
Shimon Sakaguchi
4Department of Experimental Pathology, Institute for Frontier Medical Science, Kyoto University, Kyoto 606-8507, Japan
Lloyd J. Old
5Ludwig Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center, New York, NY 10021
Hiroshi Shiku
1Second Department of Internal Medicine, Mie University School of Medicine, Mie 514-8507, Japan
CORRESPONDENCE Hiroshi Shiku: [email protected]
Received:
October 06 2004
Accepted:
January 14 2005
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2005
J Exp Med (2005) 201 (5): 681–686.
Article history
Received:
October 06 2004
Accepted:
January 14 2005
Citation
Hiroyoshi Nishikawa, Takuma Kato, Isao Tawara, Kanako Saito, Hiroaki Ikeda, Kagemasa Kuribayashi, Paul M. Allen, Robert D. Schreiber, Shimon Sakaguchi, Lloyd J. Old, Hiroshi Shiku; Definition of target antigens for naturally occurring CD4+ CD25+ regulatory T cells . J Exp Med 7 March 2005; 201 (5): 681–686. doi: https://doi.org/10.1084/jem.20041959
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement